Sweden
· Delayed Price · Currency is SEK Medimi AB Statistics
Total Valuation
Medimi AB has a market cap or net worth of SEK 6.57 million. The enterprise value is 4.39 million.
| Market Cap | 6.57M |
| Enterprise Value | 4.39M |
Important Dates
The next estimated earnings date is Friday, May 2, 2025.
| Earnings Date | May 2, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Medimi AB has 1.83 billion shares outstanding. The number of shares has increased by 71.93% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.83B |
| Shares Change (YoY) | +71.93% |
| Shares Change (QoQ) | +69.01% |
| Owned by Insiders (%) | 8.17% |
| Owned by Institutions (%) | 8.90% |
| Float | 1.66B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.37 |
| PB Ratio | 1.34 |
| P/TBV Ratio | 1.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.35 |
| EV / Sales | 0.91 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.61 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -33.82 |
Financial Efficiency
Return on equity (ROE) is -134.36% and return on invested capital (ROIC) is -62.44%.
| Return on Equity (ROE) | -134.36% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -62.44% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 801,000 |
| Profits Per Employee | -2.09M |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.63% in the last 52 weeks. The beta is -0.11, so Medimi AB's price volatility has been lower than the market average.
| Beta (5Y) | -0.11 |
| 52-Week Price Change | -81.63% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 60.73 |
| Average Volume (20 Days) | 95,629,629 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medimi AB had revenue of SEK 4.81 million and -12.53 million in losses. Loss per share was -0.01.
| Revenue | 4.81M |
| Gross Profit | 1.21M |
| Operating Income | -12.31M |
| Pretax Income | -12.53M |
| Net Income | -12.53M |
| EBITDA | -11.16M |
| EBIT | -12.31M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 3.27 million in cash and 3.00 million in debt, giving a net cash position of 269,000 or 0.00 per share.
| Cash & Cash Equivalents | 3.27M |
| Total Debt | 3.00M |
| Net Cash | 269,000 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 4.89M |
| Book Value Per Share | 0.00 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 25.22%, with operating and profit margins of -256.14% and -260.63%.
| Gross Margin | 25.22% |
| Operating Margin | -256.14% |
| Pretax Margin | -260.63% |
| Profit Margin | -260.63% |
| EBITDA Margin | -232.28% |
| EBIT Margin | -256.14% |
| FCF Margin | n/a |
Dividends & Yields
Medimi AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -71.93% |
| Shareholder Yield | -71.93% |
| Earnings Yield | -190.51% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |